David Mark Loeb
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 2%
- CAR-T cell therapy research
Papers in
- Hematology 26
- Hematopoietic Stem Cell Transplantation 16
- Acute Myeloid Leukemia Research 12
- Oncology 38
- CAR-T cell therapy research 8
- Co-authors
- Lloyd A. Greene (6 shared papers)David R. Kaplan (3 shared papers)Robert M. Stephens (2 shared papers)Tony J. Pawson (1 shared paper)Terry D. Copeland (1 shared paper)Gregory McCarty (9 shared papers)Masanori Hayashi (13 shared papers)Saraswati Sukumar (4 shared papers)
- Journals
- Pediatric Blood & Cancer (13 papers)Transplantation and Cellular Therapy (11 papers)Blood (9 papers)Journal of Pediatric Hematology/Oncology (8 papers)Cancer (7 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
David Mark Loeb
131 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 622
- Oncology 1.1k
- Hematology 467
- Pulmonary and Respiratory Medicine 1.2k
- Cellular and Molecular Neuroscience 725
Countries citing papers authored by David Mark Loeb
This map shows the geographic impact of David Mark Loeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mark Loeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mark Loeb more than expected).
Fields of papers citing papers by David Mark Loeb
This network shows the impact of papers produced by David Mark Loeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mark Loeb. The network helps show where David Mark Loeb may publish in the future.
Co-authors
The 25 scholars most cited alongside David Mark Loeb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 486 | |
| 2 | 1991 | 230 | |
| 3 | Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. | 2001 | 187 |
| 4 | Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. | 2001 | 187 |
| 5 | 1986 | 159 | |
| 6 | 2010 | 134 | |
| 7 | 2017 | 133 | |
| 8 | 1994 | 116 | |
| 9 | 2016 | 107 | |
| 10 | 2011 | 104 | |
| 11 | 1992 | 101 | |
| 12 | 1989 | 97 | |
| 13 | 2007 | 95 | |
| 14 | 2015 | 95 | |
| 15 | 2008 | 92 | |
| 16 | 2015 | 86 | |
| 17 | 2017 | 77 | |
| 18 | 2016 | 69 | |
| 19 | 2010 | 68 | |
| 20 | 2016 | 68 |
About David Mark Loeb
David Mark Loeb is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 146 papers that have together received 5.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (31 papers), Renal and related cancers (20 papers), Hematopoietic Stem Cell Transplantation (16 papers), Acute Lymphoblastic Leukemia research (12 papers), Acute Myeloid Leukemia Research (12 papers), CAR-T cell therapy research (8 papers), Cancer Genomics and Diagnostics (8 papers) and Neuroblastoma Research and Treatments (8 papers). The work is most often cited by research in Cancer Research (622 citations), Oncology (1.1k citations), Hematology (467 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Cellular and Molecular Neuroscience (725 citations). David Mark Loeb has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Lloyd A. Greene, David R. Kaplan, Robert M. Stephens, Tony J. Pawson, Terry D. Copeland, Gregory McCarty, Masanori Hayashi, Saraswati Sukumar, Dorian Korz and Allen R. Chen. Their work appears in journals such as Pediatric Blood & Cancer, Transplantation and Cellular Therapy, Blood, Journal of Pediatric Hematology/Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.